• 1. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738
• 2. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 3. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 4. Excellent humidity sensor based on ultrathin HKUST-1 nanosheets?
  Qiaoe Wang,Meiling Lian,Xiaowen Zhu,Xu Chen RSC Adv., 2021,11, 192-197
• 5. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147

Introduction to 5-Chlorobenzofuran-2-carboxamide (CAS No. 35351-20-3)

5-Chlorobenzofuran-2-carboxamide, identified by its Chemical Abstracts Service (CAS) number 35351-20-3, is a significant compound in the realm of pharmaceutical chemistry and medicinal research. This heterocyclic amide derivative exhibits a unique structural framework that has garnered considerable attention due to its potential biological activities and synthetic utility. The presence of both chloro and amide functional groups imparts distinct reactivity, making it a valuable scaffold for designing novel therapeutic agents.

The molecular structure of 5-Chlorobenzofuran-2-carboxamide consists of a benzofuran core substituted with a chloro group at the 5-position and an amide moiety at the 2-position. This configuration allows for diverse interactions with biological targets, including enzymes and receptors, which are pivotal in modulating various physiological pathways. The benzofuran ring itself is a well-documented pharmacophore in drug discovery, often associated with molecules exhibiting anti-inflammatory, antimicrobial, and anticancer properties.

In recent years, the interest in 5-Chlorobenzofuran-2-carboxamide has been fueled by its role as an intermediate in synthesizing more complex pharmacological entities. Researchers have leveraged its reactive sites to develop derivatives with enhanced binding affinity and selectivity. For instance, modifications at the amide group have been explored to fine-tune solubility and metabolic stability, while the chloro substituent serves as a handle for further functionalization via nucleophilic aromatic substitution or metal-catalyzed cross-coupling reactions.

One of the most compelling aspects of 5-Chlorobenzofuran-2-carboxamide is its potential in addressing unmet medical needs. Current studies highlight its efficacy in inhibiting specific enzymes implicated in inflammatory diseases and cancer progression. By targeting these pathological pathways, compounds derived from 5-Chlorobenzofuran-2-carboxamide hold promise for developing next-generation treatments with improved therapeutic profiles. The benzofuran scaffold, in particular, has been linked to molecules that exhibit significant cytotoxic effects against tumor cells while maintaining low toxicity toward healthy tissues.

The synthesis of 5-Chlorobenzofuran-2-carboxamide typically involves multi-step organic transformations starting from commercially available precursors. Key steps often include chlorination of a benzofuran derivative followed by amidation under controlled conditions. Advances in catalytic methods have enabled more efficient and sustainable routes to this compound, reducing waste generation and energy consumption. These innovations align with the growing emphasis on green chemistry principles in pharmaceutical manufacturing.

From a computational chemistry perspective, 5-Chlorobenzofuran-2-carboxamide has been subjected to extensive molecular modeling studies to elucidate its interactions with biological targets. Quantum mechanical calculations have provided insights into the electronic structure and reactivity of the molecule, aiding in the rational design of analogs with optimized pharmacokinetic properties. Such computational approaches are indispensable in modern drug discovery, complementing experimental efforts by predicting binding affinities and metabolic liabilities.

The pharmacological landscape of 5-Chlorobenzofuran-2-carboxamide continues to expand as new research emerges. Preclinical trials have demonstrated its ability to modulate key signaling cascades involved in neurodegenerative disorders, offering hope for novel therapeutic strategies against conditions like Alzheimer’s disease. Additionally, its antimicrobial properties have been investigated, revealing potential applications in combating resistant bacterial strains through mechanisms distinct from conventional antibiotics.

In conclusion, 5-Chlorobenzofuran-2-carboxamide (CAS No. 35351-20-3) represents a cornerstone compound in medicinal chemistry due to its versatile structural features and broad spectrum of biological activities. Its synthesis, characterized by efficient methodologies and sustainable practices, underscores the evolving standards of pharmaceutical innovation. As research progresses, derivatives of this molecule are expected to play pivotal roles in addressing diverse therapeutic challenges across multiple disease areas.

• 92426-52-3(N-(4-Chlorophenyl)benzofuran-2-carboxamide)
• 35351-30-5(5-Chloro-3,7-dimethylbenzofuran-2-carboxamide)
• 23145-14-4(5-chloro-1-benzofuran-2-carbaldehyde)
• 294878-00-5(3-amino-5-chlorobenzofuran-2-carboxamide)
• 875711-91-4(2-Benzofurancarboxamide, 5-chloro-N-[3-(1-piperidinyl)propyl]-)
• 26474-95-3(5-Chloro-3-hydroxybenzofuran-2-carboxamide)
• 389126-45-8(1-Isobenzofurancarboxamide)
• 862088-26-4(2-BENZOFURANCARBOXAMIDE, 3-AMINO-6-CHLORO-)
• 1026097-14-2(5-Aminobenzofuran-2-carboxamide)
• 50342-50-2(Benzofuran-2-carboxamide)